Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emilie Taymor
Observed names:
E Taymor,
E. Taymor
Institution:
Merck & Co., Inc., Rahway, NJ, USA (United States)
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
MSD (UK) Limited (United Kingdom)
OpenAlex ID:
A5016172383
Psy93 - Cost Effectiveness of Letermovir as Prophylaxis of Clinically Significant Cytomegalovirus Reactivation and Disease in Adult Cmv-seropositive Allogeneic Haematopoietic Stem Cell Transplant: an English Payer Perspective
2018
·
C. Brown
, A. Mayes
, et al.
·
Value in Health
·
3
Real-world outcomes of advanced melanoma patients treated with pembrolizumab who have failed prior lines of therapy.
2019
·
Wanmei Ou
, Emilie Taymor
, et al.
·
Journal of Clinical Oncology
Health care resource utilization in patients with advanced melanoma receiving immunotherapies in the real world.
2019
·
Richard Wayne Joseph
, Alicia C. Shillington
, et al.
·
Journal of Clinical Oncology
Pin97 - Validating Data on Hepatitis C Testing in the Uk in the Primary Care Setting
2018
·
C. Praet
, A.M. Elsharkawy
, et al.
·
Value in Health
Cost-Comparison Between the Etonogestrel Implant and the Medroxyprogesterone Acetate Injectable: Number of Unintended Pregnancies and Financial Impact
2017
·
C Praet
, E Taymor
, et al.
·
Value in Health
PDF
O Indicative Budget Impact Of Posaconazole Versus Itraconazole In Invasive Fungal Infection Prophylaxis In Adult Patients With Aml/Mds
2017
·
HB Ahir
, A Sung
, et al.
·
Value in Health
Indicative Budget Impact Of Posaconazole Versus Fluconazole In Invasive Fungal Infection Prophylaxis In Adult Patients With AML/MDS
2017
·
HB Ahir
, E Taymor
, et al.
·
Value in Health
Policy recommendation to members of the Russian Federal Government: Strong tobacco control measures as a key to reducing mortality
2016
·
Anna Louise Barr
, Teresa Hall
, et al.
·
Journal of Health Inequalities
PDF
Show more works
View as search
Works count:
8
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type